Herve Hoppenot
Director · 1 filing · Latest: Jun 8, 2026
Maze Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
INCY | HERVE HOPPENOT | — | Nov 10, 2025 | Proposed Sale | $105.46 | 187,500 | $19.8M | — |
Director · 1 filing · Latest: Jun 8, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
INCY | HERVE HOPPENOT | — | Nov 10, 2025 | Proposed Sale | $105.46 | 187,500 | $19.8M | — |